Zafgen Lands $33,000,000 Series C Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4457e7de-f132-4f30-9d70-dc17c8266a20&Preview=1 -
Date
7/7/2011 -
Company Name
Zafgen -
Mailing Address
5 Cambridge Center Floor 2 Cambridge, MA 02142 -
Company Description
The company is developing novel therapeutics for the treatment of obesity. -
Website
http://www.zafgen.com -
Transaction Type
Venture Equity -
Transaction Amount
$33,000,000 -
Transaction Round
Series C -
Proceeds Purposes
Proceeds from the financing will be used to support development of Zafgen’s pipeline and to advance its lead methionine aminopeptidase 2 (MetAP2) inhibitor for the treatment of severe obesity into Phase 2 clinical studies. -
M&A Terms
-
Venture Investor
Atlas Venture -
Venture Investor
Third Rock Ventures
